ClinicalTrials.Veeva

Menu
R

Rigshospitalet | Glostrup - Intestinal Failure and Liver Disease Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-6482
Belzutifan
MK-6482-015

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 2 total trials

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pa...

Enrolling
Advanced Gastrointestinal Stromal Tumor
HIF-2α Mutated Cancers
Drug: Belzutifan

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Rigshospitalet logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems